Screener
Iovance Biotherapeutics, Inc. IOVA Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Intangible assets, net | 263,894 | 279,324 |
| Operating lease right-of-use assets | 43,480 | 45,899 |
| Restricted cash | 6,005 | 5,980 |
| Long-term assets | 6,431 | 8,166 |
| Total Assets | $915,531 | $913,170 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current Liabilities | ||
| Accounts payable | $26,211 | $22,159 |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s other non-current assets?
- Iovance Biotherapeutics, Inc. (IOVA) reported other non-current assets of $6.43M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s other non-current assets changed year-over-year?
- Iovance Biotherapeutics, Inc.'s other non-current assets decreased by 37.7% year-over-year, from $10.32M to $6.43M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s other non-current assets has grown at a -8.8% compound annual growth rate (CAGR), from $12.92M to $8.17M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Iovance Biotherapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude